Orphazyme A/S announced earnings results for the half year ended June 30, 2021. For the half year, the company announced sales was DKK 13.152 million. Operating loss was DKK 465.698 million compared to DKK 245.555 million a year ago. Net loss was DKK 463.780 million compared to DKK 251.415 million a year ago. Basic loss per share from continuing operations was DKK 13.27 compared to DKK 9.77 a year ago.